Newscrate logo

Browse the latest oncology news online for free

Search results for "oncology"

Is it time to get into biopharma player Kura Oncology? Jim Cramer digs in
Is it time to get into biopharma player Kura Oncology? Jim Cramer digs in

CNBC's Jim Cramer talks about small-cap biotech company Kura Oncology and analyzes the company's stock performance. Read more

Cnbc - Dec 20
Cancer Biomarkers Market to Hit USD 74.3 Billion by 2035, Driven by Precision Oncology
Cancer Biomarkers Market to Hit USD 74.3 Billion by 2035, Driven by Precision Oncology

The Cancer Biomarkers Market is entering a transformative decade as global healthcare systems accelerate the shift toward earlier cancer detection, personalized treatment, and minimally invasive diagnostic tools. Valued at USD 26.8 billion in 2025, the market is projected to reach Read more

Openpr.com - Nov 17
Pyxis Oncology (NASDAQ:PYXS) Coverage Initiated by Analysts at Stifel Nicolaus
Pyxis Oncology (NASDAQ:PYXS) Coverage Initiated by Analysts at Stifel Nicolaus

Stifel Nicolaus initiated coverage on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a report issued on Monday. The firm issued a buy rating and a $9.00 price objective on the stock. A number of other brokerages have also commented on PYXS. Guggenheim started coverage on Pyxis Oncology i... Read more

Defenseworld Net - Nov 04
CTCL (Cutaneous T-Cell-Lymphoma) Market Forecasted to Grow Steadily at a CAGR of 2.0% as Demand for Precision Oncology and Advanced Therapies Rises
CTCL (Cutaneous T-Cell-Lymphoma) Market Forecasted to Grow Steadily at a CAGR of 2.0% as Demand for Precision Oncology and Advanced Therapies Rises

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CTCL (Cutaneous T-Cell-Lymphoma) Market- (By Type (Mycosis Fungoides (MF), Sézary Syndrome (SS), And Other Related Diseases), By Therapy (Radiotherapy, Chemotherapy, Immunotherapy, Stem Cell Transpla... Read more

Openpr.com - Nov 04
Asia Pacific Generic Oncology Sterile Injectable Market to Get an Explosive Growth | Eli Lilly and Company, Biocon Ltd., Sun Pharmaceutical Industries Ltd.
Asia Pacific Generic Oncology Sterile Injectable Market to Get an Explosive Growth | Eli Lilly and Company, Biocon Ltd., Sun Pharmaceutical Industries Ltd.

The Asia Pacific Generic Oncology Sterile Injectable market is estimated to be valued at USD 1,303.8 Mn in 2025 and is expected to reach USD 8,832.6 Mn by 2032, growing at a compound annual growth rate CAGR of 12.2% from Read more

Openpr.com - Nov 04
Oncology Radiopharmaceuticals Market Forecast 2025-2032: Emerging Trends, Market Drivers, and Strategic Insights Revealed in New Study| Novartis AG, Curium, and Siemens Healthcare GmbH
Oncology Radiopharmaceuticals Market Forecast 2025-2032: Emerging Trends, Market Drivers, and Strategic Insights Revealed in New Study| Novartis AG, Curium, and Siemens Healthcare GmbH

The Oncology Radiopharmaceuticals market is estimated to be valued at USD 3,462.8 Mn in 2025 and is expected to reach USD 5,206.8 Mn by 2032, growing at a compound annual growth rate CAGR of 45.7% from 2025 to 2032.➤ The Read more

Openpr.com - Nov 04
Fighting Breast Cancer Together – A Conversation With Texas Oncology, Texas Breast Specialists
Fighting Breast Cancer Together – A Conversation With Texas Oncology, Texas Breast Specialists

Expert Breast Cancer Care Close to Home: What Sets Texas Breast Specialists Apart October is Breast Cancer Awareness Month—a time to remind women about the importance of screenings and early detection. Studio 512 sat down with Dr. Aimee Mackey, breast surgeon with Texas Breast Specialists, the su... Read more

Kxan - Oct 30
Documentary Featuring Translational Oncology Highlighted with Emmy Nominations
Documentary Featuring Translational Oncology Highlighted with Emmy Nominations

DVM360 (Oct. 17) – Shelter Me: The Cancer Pioneer premiered on PBS in December 2024 and was recently brought more prominently into the national spotlight with a pair of 2025 Daytime Emmys nominations. It features veterinarians... Read More >The post Documentary Featuring Translational Oncology Hi... Read more

University Of Illinois Urbana-champaign - Oct 21
NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board
NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board

CALABASAS, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today announced the appointment of Dr. Alexandra M. Mil... Read more

Globenewswire_fr - Oct 01